References
- Abe SK, Inoue M, Sawada N, et al (2015). Hepatitis B and C infection and risk of lymphoid malignancies. Cancer Epidemiol, 39, 562-6. https://doi.org/10.1016/j.canep.2015.06.002
- Baskshi N, Maghfoor I (2012). The current lymphoma Classification: new concepts and practical applications triumphs and woes. Ann Saudi Med, 32, 296-305. https://doi.org/10.5144/0256-4947.2012.296
- Beam E, Lesnick T, Kremers W, et al (2015). Cytomegalovirus disease is associated with higher all-cause mortality after lung transplantation despite extended antiviral prophylaxis. Clin Transplant.
- Campo E, Swerdlow SH, Harris NL, et al (2011). The 2008 WHO Classification of lymphoid neoplasm and beyond. Blood J, 117, 5019-32. https://doi.org/10.1182/blood-2011-01-293050
- Chakraborty R, Mukkamalla SK, Gutzmore G, et al (2015). A case of Hodgkin's lymphoma with severely impaired liver functions treated successfully with gemcitabine followed by ABVD. J Blood Med, 6, 93-97.
- Chang C, Middeldrop J, Yu KJ, et al (2013). Characterization of ELISA detection of broad-spectrum anti-EBV antibodies associated with nasopharyngeal carcinoma. J Med Virol, 85, 524-9. https://doi.org/10.1002/jmv.23498
- Christenson ES, Teply B, Agrawal V, et al (2015). Human Herpesvirus 8-Related Primary Effusion Lymphoma after Liver Transplantation. Am J Transplant, 15, 2762-6. https://doi.org/10.1111/ajt.13321
- Coghill AE, Hildesheim A (2014). EBV antibodies and the risk of associated malignancies. Am J Epidemiol, 180, 687-95. https://doi.org/10.1093/aje/kwu176
- Corti M, de Dios Soler M, Bare P, et al (2010). AIDS related lymphomas: Histopathological subtypes and association with Epstein Barr virus and Human Herpes virus type -8. Medicina (B Aires), 70, 151-8.
- D'Antonio A, Addesso M, Memoli D, et al (2011). Lymph node-based disease and HHV-8/KSHV infection in HIV seronegative patients: report of three new cases of a heterogeneous group of diseases. Int J Hematol, 93, 795-801. https://doi.org/10.1007/s12185-011-0849-0
- Dai C, Hidemi I, Tomohiro M, et al (2014). Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol, 164, 536-45. https://doi.org/10.1111/bjh.12659
- De Martel C, Ferlay J, Franceschi S, et al (2012). Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol, 13, 607-15. https://doi.org/10.1016/S1470-2045(12)70137-7
- Fisher SG, Fisher RI (2004). The epidemiology of Non- Hodgikin’s lymphoma. Oncogene, 23, 6524-34. https://doi.org/10.1038/sj.onc.1207843
- Ganem D (2010). KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. J Clin Invest, 120, 939-49. https://doi.org/10.1172/JCI40567
- Grinde B (2013). Herpes viruses: latency and reactivation - viral strategies and host response, J Oral Microbiol, 5.
- Han Van KJ (2015). New developments in the pathology of malignant lymphoma. J Hematop, 8, 225-34. https://doi.org/10.1007/s12308-015-0262-3
- Irsai G, Tampu-Kiss T, Dezső B, et al (2012). Complications of systemic cytomegalovirus infection in therapy-resistant Hodgkin's lymphoma. Orv Hetil, 153, 751-5. https://doi.org/10.1556/OH.2012.29364
- Jaffe ES, Harris NL, Stein H, et al (2001). World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of Haemopoietic and Lymphoid Tissues (eds.). Lyon, IARC Press, 75-107.
- Jaffe ES, Harris NL, Stein H, et al (2008). Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. Blood, 112, 4384-99. https://doi.org/10.1182/blood-2008-07-077982
- Kate RS, James OA, Barry WH, et al (2012). Non - Hodgkin lymphoma. Lancet, 380, 848-857. https://doi.org/10.1016/S0140-6736(12)60605-9
- Kathy KL, Rory NG, Christopher L, et al (2014). Deranged liver function tests in a patient with Hodgkin lymphoma. J Clin Virol, 62, 118-21.
- Kutikhin AG, Yuzhalin AE, Brusina EB, et al (2012). Role of infectious agents in the emergence of malignant tumors. Zh Mikrobiol Epidemiol Immunolobiol, 5, 104-14.
- Lindsay MM, Todd MG, Christina AC, et al (2014). Hepatitis B and C virus infection and risk of non-Hodgkin lymphoma among solid organ transplant recepient. Haematologica, 99, 70-3.
- Mahmoud YA, Mumtaz GR, Riome S, et al (2013). The epidemiology of hepatitis C virus in Egypt. BMC Infect Diseases, 13, 288. https://doi.org/10.1186/1471-2334-13-288
- Marchesi F, Pimpinelli F, Gumenyuk S, et al (2015). CMV reactivation after autologus stem cell transplantation in myeloma and lymphoma patients. World J Transplant, 5, 129-36. https://doi.org/10.5500/wjt.v5.i3.129
- Marianna P, Dimitrios K, Georgios K, et al (2014). Seroprevalence of HHV-6 and HHV-8 among blood donors in Greece. Virol J, 11, 153. https://doi.org/10.1186/1743-422X-11-153
- Mariotti J, Maura F, Spina F, et al (2014). Impact of Cytomegalovirus replication and Cytomegalovirus serostatus on the outcome of patients with B cell lymphoma after allogeneic stem cell transplantation. Biol Blood Marrow Transplant, 20, 885-90. https://doi.org/10.1016/j.bbmt.2014.02.015
- Mesri EA, Cesarman E, Boshoff C (2010). Kaposi Sarcoma and its associated herpes virus. Nature Rev Cancer, 10, 707-19. https://doi.org/10.1038/nrc2888
- Moore PS, Chang Y (2010). Why do viruses cause cancer? Highlights of the first century of human tumor virology. Nature Rev Cancer, 10, 878-89. https://doi.org/10.1038/nrc2961
- Mwakigonja AR, Kaaya EE, Mgaya EM (2012). Malignant lymphomas (ML) and HIV Infection in Tanzania. J Exp Clin Cancer Res, 10, 27-9.
- Nakamura H, Tsuta K, Nakagawa T, et al (2015). Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma in the pericardium: A case with latency type III Epstein-Barr virus infection showing good prognosis without chemotherapy. Pathol Res Pract, 211, 1010-13. https://doi.org/10.1016/j.prp.2015.08.002
- Nath A., Agarwal R., Malhorta P, et al (2010). Prevalence of HBV in NHL. A systemic review and meta-analysis. Intern Med J, 40, 633-41. https://doi.org/10.1111/j.1445-5994.2009.02060.x
- Ogawa Y, Watanabe D, Hirota K, et al (2014). Rapid multiorgan failure due to large H-cell lymphomas arising in HHV-8 associated multicentric Castleman's disease in a patient with HIV infection. Intern Med, 53, 2805-9. https://doi.org/10.2169/internalmedicine.53.2212
- Peveling-Oberhag J, Arcaini L, Hansman ML, et al (2013). Hepatitis C associated B cell NHL. Epidemiology, molecular signature and clinical management. J Hepatol, 59, 169-77. https://doi.org/10.1016/j.jhep.2013.03.018
- Pinzone MR, Berretta M, Cacopardo B, et al (2015). Epstein-barr virus- and Kaposi sarcoma-associated herpesvirus-related malignancies in the setting of human immunodeficiency virus infection. Semin Oncol, 42, 258-71. https://doi.org/10.1053/j.seminoncol.2014.12.026
- Polizzotto MN, Uldrick TS, Wyvill KM, et al (2015). Clinical features and outcome of patients with symptomatic KSHVassociated inflammation. Clin Infect Dis, 996.
- Qingqing C, Kailin C, Ken HY (2015). Epstein-Barr viruspositive T/NK-cell lymphoproliferative disorders. Experimental Molecular Med, 47, 133. https://doi.org/10.1038/emm.2014.105
- Saadettin K, Ibrahim B, Şükran Ü, et al (2013). Clinical features and prognostic factors of Hodgkin's lymphoma. Balkan Med J, 30, 178-85. https://doi.org/10.5152/balkanmedj.2012.110
- Seyed A, Mohamed RG, Kamran G, et al (2014). Hepatitis-C infection incidence among the Non Hodgkin-B cell Lymphoma patients. Iran J Cancer Prev, 7, 147-51.
- Swerdlow SH, Campo E, Harris NL, et al (2008). WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. (4th eds.) IARC Press, Lyon.
- Thomas B, Florian L, Jerome S, et al (2002). Reliability of lymphoma classification in bone marrow trephines. BrJ Hematol, 118, 470-6. https://doi.org/10.1046/j.1365-2141.2002.03605.x
- Tyagi M, Ambiya V, Mathai A, et al (2015). Atypical CMV retinitis in NHL. BMJ, Case Rep.
- Wang Y, Liu X, Chen Y (2015). Adult Systemic EBV Positive T cell Lympho-proliferative disease. A case report. Exp Ther Med, 10, 1025-8. https://doi.org/10.3892/etm.2015.2601
- Yi HZ, Chen JJ, Cen H, et al (2014). Association between infection of Hepatitis B virus and onset risk of B- cell Non-Hodgkin's lymphoma. Med Oncol, 31, 84. https://doi.org/10.1007/s12032-014-0084-7
Cited by
- New developments in the pathology of malignant lymphoma: a review of the literature published from June–August 2016 vol.9, pp.3, 2016, https://doi.org/10.1007/s12308-016-0284-5